Stanton J. Rowe has been Chief Scientific Officer since 2008 and also serves as Corporate Vice President, Advanced Technology at Edwards Lifesciences. He joined the company in 2004 when Edwards acquired Percutaneous Valve Technologies, a company he helped found in 1999 and served as President and CEO. Previously, Rowe was Corporate Vice President of Business Development and Strategic Planning for Datascope, and was Vice President of Business Development for Johnson & Johnson’s interventional systems division (JJIS) in Warren, New Jersey where he was responsible for the company’s coronary stent development efforts. At JJIS and the related Cordis Corporation, Rowe held a variety of positions with increasing levels of responsibility, including heading the company’s business development, advanced technology, worldwide clinical research and marketing groups. Rowe joined Cordis after holding several positions in product management for a number of medical device companies. He is on the board of directors of InSeal Medical, Ltd., Neural Analytics and the Discovery Science Center in Orange County, as well as on the advisory boards for the engineering or biomedical engineering schools at UC Irvine, Georgia Tech and Brown University. Rowe received a bachelor’s degree from the University of Alabama.